National Alzheimer’s Disease Month: The Connection between Alzheimer’s Disease and Diabetes

Celebrated as National Alzheimer’s Disease Month, the month of November is recognized as a nationwide opportunity to raise awareness for those afflicted with the disease. Currently, there are an estimated 5.8 million Americans living with Alzheimer’s disease (AD) – the 6th leading cause of death in the nation. Alzheimer’s disease has seen a dramatic increase in mortality rate of 145% since the year 2000 and continues to grow in incidence.

Although AD mostly affects individuals over the age of 65, early-onset Alzheimer’s may be more prevalent than previously thought, occurring at a rate of close to 6%, rather than the 1-2% rate presumed from prior studies. The number of Americans suffering from Alzheimer’s is growing quickly; projections forecast that by 2050 the number of people living with AD in the United States will grow to approximately 14 million.

Continue reading

 The Complexities of Physician Compensation

Although overall physician salaries continue to rise steadily, the latest research reveals the caveats and complexities of physician compensation, such as a widening gender pay gap and vast differences between specialties. Published annually, the Medscape Physician Compensation Report is the most comprehensive and widely used physician salary survey in the United States, analyzing compensation, hours worked, time spent with patients, and what practitioners find the most rewarding and challenging about their jobs. Over 20,000 U.S. physicians across 30 specialties responded to this year’s online survey, delivering both good and bad news about the state of the healthcare system.

Continue reading

The Race to Longevity  

A growing body of research demonstrates significant discoveries and advancements in knowledge  into potential biomedical strategies for reversing the aging process. Today, researchers continue to study animal and human abilities to regenerate cells, aiming to diminish cognitive decline, immune system weakening, and other adverse effects of the biological aging process. Meanwhile, healthcare and biotech companies race to “find the key” to reversing the aging process, bringing the market valuation of anti-aging medicine to a projected $610 billion by 2025 from current estimates of $110 billion. Investors are pouring millions into start-up companies that focus on anti-aging and regenerative medical research, in hopes of being the first organization to make a breakthrough – bringing a successful solution to aging to the public.

Continue reading